Biden administration names 10 drugs for Medicare price negotiations

The Biden administration has announced the first 10 medications that will be subject to price negotiations under Medicare — a key Democratic priority stemming from last year’s Inflation Reduction Act. Larry Levitt, executive vice president for health policy at KFF, joined CBS News to discuss what the negotiations mean.